Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Access to linked administrative healthcare utilization data for pharmacoepidemiology and pharmacoeconomics research in Canada
Pharmacoepidemiology and Drug Safety, 09/02/09
Rawson NSB – As Canada moves towards a life–cycle management approach to drug regulation, more post–marketing studies will be required, potentially using administrative data. Linked patient–level drug and healthcare data are presently accessible to pharmaceutical industry researchers in four provinces, although only logistically realistic in three and limited to seniors and low–income individuals in two. Collaborative endeavours to improve access to provincial data and to create other data resources should be encouraged.
Related Articles
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: Medicare, Medicaid and Other US Government Payers Perspectives: The ISPOR Drug Cost Task Force Report-Part IV
Value in Health, 10/19/09
Relevance Score: 84%
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective: The ISPOR Drug Cost Task Force Report-Part VI
Value in Health, 10/29/09
Relevance Score: 82%
The possible macroeconomic impact on the UK of an influenza pandemic
Health Economics, 10/29/09
Relevance Score: 80%
A simple cost-effective high performance liquid chromatographic assay of sulphadoxine in whole blood spotted on filter paper for field studies
Malaria Journal, 10/27/09
Relevance Score: 80%
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance
Clinical Pharmacokinetics, 10/15/09
Relevance Score: 80%
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia
Health Policy, 12/16/09
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Cost-effectiveness of single agent, uptitration and switching statin treatment strategies for lipid lowering in Sweden
Current Medical Research and Opinion, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


